Bharat Biotech

Modest reduction in neutralisation by a factor of 1.95 against B.1.617 variant compared to vaccine variant D614G

In support of their proposal, Bharat Biotech has submitted updated accelerated and real-time stability data of Coaxin along with…

30 per cent survey respondents say they observed or experienced some irregularities on the ground like false certification to…

Also asks SII, Bharat Biotech to disclose COVID-19 vaccine capacity, as there 'has to be sense of responsibility, urgency'

COVAXIN has been developed on the WHO pre-qualified verocell platform, which is globally recognised with a well-established track…

India will begin immunising the public from next month, starting with those over 50 or with medical conditions

Dr Abdul Ghafur, Coordinator, Chennai Declaration on AMR and Consultant in Infectious Diseases, Apollo Hospital, Chennai explains…

Results have not yet undergone peer review, findings are provisional, and the conclusions/final results may differ

COVAXIN is a highly purified and inactivated two dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with a…

Three subjects were enrolled today The human trial of Bharat Biotech's anti-COVID-19 vaccine Covaxin began at Rohtak's…